NCLEX-RN® Health Promotion and Disease Prevention: Screening, Immunizations, and Lifestyle
Health promotion content for the NCLEX-RN®: age-appropriate screening schedules, immunization contraindications, primary vs. secondary vs. tertiary prevention, and lifestyle modification counselling.
The big picture
Health Promotion and Maintenance accounts for 6–12% of the NCLEX-RN® exam. Questions focus on across-the-lifespan screening recommendations, immunization schedules, lifestyle counseling, and primary versus secondary versus tertiary prevention. Nurses are the frontline of preventive care — knowing when to screen, what vaccines to recommend, and how to counsel patients on lifestyle changes is a core competency.
Levels of prevention
| Level | Definition | Examples |
|---|---|---|
| Primary | Prevent the disease from occurring | Immunizations, health education, lifestyle counseling, fluoridated water |
| Secondary | Early detection and treatment before symptoms become severe | Screening tests (mammogram, colonoscopy, Pap smear), tuberculin skin test |
| Tertiary | Reduce complications and restore function in someone with established disease | Cardiac rehabilitation after MI, dialysis for CKD, physical therapy after stroke |
NCLEX® tip: A mammogram in an asymptomatic woman is secondary prevention — it does not prevent breast cancer; it detects it early. Teaching a teenager how to use sunscreen is primary prevention — it prevents skin cancer.
Cancer screening recommendations
Based on current U.S. Preventive Services Task Force (USPSTF) recommendations, which NCLEX® references:
Breast cancer
| Screening | Recommendation |
|---|---|
| Mammography | Average risk: begin at 40–50 years (controversy; USPSTF recommends biennial starting at 50; ACS recommends annual starting at 45; discuss with provider); high risk: begin earlier + MRI |
| Breast self-exam (BSE) | No longer routinely recommended — instead, "breast awareness"; report any new changes to provider |
Cervical cancer
| Age | Recommendation |
|---|---|
| < 21 years | No screening |
| 21–29 years | Pap smear every 3 years |
| 30–65 years | Pap + HPV co-test every 5 years OR Pap alone every 3 years |
| > 65 years | Can stop with adequate prior screening |
Colorectal cancer
- Start at age 45 for average-risk individuals (USPSTF 2021 update)
- Options: colonoscopy every 10 years (gold standard); stool-based tests annually (FOBT, FIT); CT colonography every 5 years
- High-risk (family history, IBD, prior polyps): begin earlier and screen more often
Lung cancer
- Annual low-dose CT scan for adults age 50–80 who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years
Prostate cancer
- PSA testing is optional (shared decision-making) for men 55–69 years
- Not recommended for men > 70 years (benefits may not outweigh harms)
Other key screenings
| Screening | Who | Interval |
|---|---|---|
| Blood pressure | All adults | At every healthcare visit |
| Diabetes (type 2) | Adults ≥ 35 years who are overweight/obese | Every 3 years if normal |
| Lipid panel | Men ≥ 35 years; women ≥ 45 years; younger if high risk | Per risk assessment |
| HIV | All adults 15–65 years | At least once; annually if high-risk |
| Hepatitis C | All adults 18–79 years | Once; repeat if ongoing risk |
| Osteoporosis (DEXA) | Women ≥ 65; younger women with risk factors | Every 2 years or as indicated |
| Abdominal aortic aneurysm (AAA) | Men 65–75 who have smoked | One-time ultrasound |
| Depression | All adults | Annually (PHQ-2 or PHQ-9) |
Immunization schedule highlights
Adult immunizations (ACIP recommendations — key NCLEX® vaccines)
| Vaccine | Who needs it | Key nursing point |
|---|---|---|
| Influenza | All individuals ≥ 6 months annually | Inactivated vaccine (IIV) is safe for pregnant women; live attenuated (LAIV) nasal spray not for immunocompromised or pregnant |
| Tdap/Td | Tdap once in adulthood; Td booster every 10 years; Tdap in every pregnancy (27–36 weeks) | Adults who've never received Tdap (vs. Td only) need one Tdap dose |
| COVID-19 | Per current CDC schedule | Updated annually |
| Pneumococcal | Adults ≥ 65; younger adults with certain conditions | Options: PCV20 (Prevnar 20), PCV21 (Capvaxive — approved June 2024), or PPSV23; consult current ACIP schedule |
| Shingles (RZV/Shingrix) | Adults ≥ 50 | Two-dose series (0 and 2–6 months); preferred over ZOSTAVAX |
| HPV (Gardasil 9) | Age 11–12 (can start at 9); catch-up through age 26; shared decision-making 27–45 | 2-dose series if started < 15; 3-dose series if started ≥ 15 |
| Hepatitis B | All unvaccinated adults; all infants | 3-dose series; check anti-HBs after series to confirm immunity in high-risk groups |
| MMR | Unvaccinated adults; 1–2 doses | Contraindicated in pregnancy and immunocompromised; live vaccine |
| Varicella | Unvaccinated, non-immune adults | 2-dose series; contraindicated in pregnancy and immunocompromised; live vaccine |
Contraindications to live vaccines
Live vaccines (MMR, varicella, LAIV, yellow fever, rotavirus) are contraindicated in:
- Pregnancy
- Immunocompromised individuals (HIV with CD4 < 200, chemotherapy, high-dose corticosteroids)
- Severely immunodeficient household contacts
Childhood immunization schedule (key milestones)
| Age | Vaccines |
|---|---|
| Birth | Hepatitis B (dose 1) |
| 2 months | DTaP, IPV, Hib, PCV15/20, Rotavirus |
| 4 months | Same as 2 months (dose 2) |
| 6 months | Same + influenza (annually from here) |
| 12–15 months | MMR, varicella, Hib (final), PCV (final) |
| 4–6 years | DTaP (booster), IPV (final), MMR (dose 2), varicella (dose 2) |
| 11–12 years | Tdap, meningococcal (MenACWY), HPV series |
Lifestyle counseling
The "5 As" of behavioral counseling (NCLEX® framework)
| Step | What the nurse does |
|---|---|
| Ask | Assess the behavior — "Do you currently smoke?" |
| Advise | Give clear advice to change — "Quitting smoking is the single most important thing you can do for your health." |
| Assess | Assess readiness to change — "Are you interested in making any changes?" |
| Assist | Help with a plan — resources, medications, support |
| Arrange | Follow-up — schedule a return visit or referral |
Motivational interviewing — tested on NCLEX®
Motivational interviewing (MI) is a patient-centered counseling approach that helps patients explore and resolve ambivalence about behavior change.
Key principles:
- Express empathy — understand the patient's perspective
- Develop discrepancy — help the patient see the gap between current behavior and their own goals
- Roll with resistance — do not argue; step back when met with resistance
- Support self-efficacy — believe and express that the patient can change
What it sounds like:
- "What are some reasons you might want to quit smoking?"
- "On a scale of 1–10, how important is it to you to make this change?"
- "What do you think might get in the way?"
Smoking cessation counseling
- Set a quit date
- Pharmacological options: nicotine replacement therapy (NRT — patch, gum, lozenge, inhaler); bupropion (Zyban); varenicline (Chantix/Champix)
- Behavioral strategies: identify triggers, avoid high-risk situations, plan for cravings
- Combination NRT (patch + short-acting) is more effective than single-product NRT
Alcohol use counseling
- CAGE screening tool (4 questions: Cut down, Annoyed, Guilty, Eye-opener)
- AUDIT-C: validated 3-question screen
- Brief intervention (SBIRT): brief counseling shown to reduce hazardous drinking
- Referral to specialized treatment when dependent
Health promotion across the lifespan
Anticipatory guidance by age
| Age group | Key health promotion topics |
|---|---|
| Infants | Safe sleep (back to sleep), breastfeeding, immunizations, milestone monitoring |
| Toddlers | Dental care (first dentist visit by age 1), car seat safety, poison prevention, lead screening |
| School-age | Helmet use, bicycle/pedestrian safety, screen time limits, dental hygiene |
| Adolescents | Mental health screening, substance use prevention, reproductive health, sports safety |
| Adults | Cardiovascular risk reduction, cancer screening, STI prevention, stress management |
| Older adults | Fall prevention, medication review, cognitive screening, isolation prevention |
NCLEX® clinical judgment focus
Health promotion questions ask:
- Which screening is appropriate for this patient? (Know age + risk thresholds)
- Which teaching is correct? (Know the guidelines)
- Which intervention is primary, secondary, or tertiary prevention?
Common NCLEX® traps:
- Teaching breast self-exam as a recommended screening tool — no longer recommended routinely by USPSTF
- Starting colorectal screening at 50 (not 45 — updated USPSTF 2021)
- Recommending LAIV (nasal spray flu vaccine) to an immunocompromised patient — contraindicated; use IIV
- Giving MMR to a pregnant patient — live vaccine, absolutely contraindicated
FAQ
What is the difference between primary and secondary prevention?
Primary prevention stops disease before it starts (vaccines, lifestyle counseling). Secondary prevention detects disease early in its preclinical stage to prevent progression (cancer screening). The distinction depends on whether the disease has begun — screening finds it early but doesn't prevent it from occurring.
When should colorectal cancer screening begin?
At age 45 for average-risk individuals, per the updated USPSTF 2021 recommendation. The previous cutoff was 50. High-risk individuals (family history of CRC or polyps, IBD, familial syndromes) should begin earlier — typically 10 years before the youngest affected relative's diagnosis or age 40, whichever comes first.
Who should NOT receive live vaccines?
Immunocompromised individuals (HIV with low CD4, chemotherapy, high-dose steroids), pregnant women, and anyone with severe allergic reactions to vaccine components. Household contacts of immunocompromised individuals can generally still receive most live vaccines, with the exception of oral polio vaccine (no longer used in the US).
What does the Tdap vaccine during pregnancy do?
Vaccinating pregnant women between 27–36 weeks of gestation ensures high titers of maternal antibodies are present at delivery. These antibodies pass to the fetus through the placenta and provide protection against pertussis (whooping cough) during the first weeks of life — before the infant is old enough to receive their own DTaP doses.
How do you assess readiness to change?
Use the Transtheoretical Model stages: Precontemplation (not considering change), Contemplation (thinking about it), Preparation (making a plan), Action (implementing change), Maintenance (sustaining change). Match your intervention to the stage — providing quitting strategies to someone in precontemplation is premature; exploring ambivalence is more appropriate.
Key takeaways
- Prevention levels: Primary = prevent occurrence. Secondary = early detection. Tertiary = reduce complications.
- Cancer screening: Cervical (Pap q3yr from 21; co-test q5yr from 30). Colorectal from 45. Breast mammography from 45–50. Lung CT for smokers 50–80 with 20 pack-years.
- Vaccines: Live vaccines (MMR, varicella, LAIV) contraindicated in pregnancy and immunocompromised. Tdap every pregnancy (27–36 weeks). Shingrix (≥ 50), HPV (11–12 through 26).
- Counseling: 5 As framework. Motivational interviewing supports patient autonomy and ambivalence exploration.
Sources: NCSBN NCLEX-RN® 2023 Test Plan; U.S. Preventive Services Task Force (USPSTF) Recommendations 2021–2024; CDC Advisory Committee on Immunization Practices (ACIP) Adult Immunisation Schedule 2024; HHS Healthy People 2030.
See also:
- Adult Development and Aging: Geriatric Syndromes
- NCLEX-RN® Cultural Safety and Health Disparities
- NCLEX-RN® Patient Safety Guide
- NCLEX-RN® Pediatrics: Growth, Development & Safety
- NCLEX-RN® Pharmacology Guide (Immunizations)
Practice on RN Clarity: Question Bank · Flashcards · Diagnostic Quiz